Global health financing is facing growing political and budgetary scrutiny. In an era marked by geopolitical rivalries, multiple crises and competing domestic priorities, international engagement is often assessed through a narrow lens of short-term national interest. This Monitor argues that such a perspective underestimates the true value of global health investments and neglects their multidimensional and reciprocal benefits. The underlying study provides a systematic analysis of the economic value generated by global health engagement, with a particular focus on Germany.
Drawing on a review of 90 academic publications and 12 expert interviews, the analysis identifies three core economic channels through which global health investments create reciprocal benefits:
- prevention and mitigation of global health crises
- trade and export effects associated with health-related development assistance
- global health research and development as a driver of domestic innovation
First, investments in pandemic prevention, preparedness and resilient health systems substantially reduce macroeconomic risks. Health crises such as COVID‑19 or the growing threat of antimicrobial resistance impose significant losses on global GDP and productivity. The evidence indicates that timely and cooperative global health action can avert large-scale economic disruptions and protect long-term economic stability.
Second, health-related development assistance supports trade and export growth by lowering transaction costs, fostering trust and enabling durable economic partnerships. Germany’s engagement in global health has been shown to generate spillover effects that benefit domestic industries and employment while strengthening economic ties with strategically important regions.
Third, global health research and development acts as a powerful engine for innovation within Germany. A high share of public R&D funding is retained domestically, contributing to job creation, value added, patents and the competitiveness of the German health industry. International research collaborations further reinforce innovation ecosystems, supply chain resilience and technological leadership.
Overall, the Monitor demonstrates that global health engagement should be understood as a strategic investment rather than a discretionary expense. Its value lies not only in measurable financial returns, but also in its long-term contributions to economic resilience, innovation capacity, international cooperation and foreign policy objectives. The findings call for a reframing of the policy narrative and for embedding global health more firmly within Germany’s economic, innovation and foreign policy strategies.
Read the entire Monitor: “The Value of Global Health” here as a PDF.
